Respiratory Tract Infection Treatment Market Is Driven By...

added article Other

2024-02-19 09:29:57 -

Respiratory Tract Infection Treatment Market Is Driven By Increasing Incidence Of Respiratory Diseases

The global respiratory tract infection treatment market is estimated to be valued at US$ 103.19 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024 to 2031. Key players operating in the respiratory tract infection treatment market are Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc,...

0 Comments 0 Shares 1203 Views 0 Reviews